Luis Jara-PalomaresDr

Dr. Jara-Palomares’s research activity in this field has resulted in 197 publications, with 3,635 citations, and 33.9% of his works ranked among the top 25% most cited worldwide. A total of 58.4% of manuscripts were published in first-quartile journals according to CiteScore percentiles. His publications have had a significant impact across 22 categories (Scopus), with the most relevant being: 1. Venous Thromboembolism; Cancer; Anticoagulant Agents: 26 documents. 2. Pulmonary Embolism; Embolectomy. 3. Blood Clot Lysis: 12 documents; Pulmonary Embolism; Fibrin Fragment D; Vein Thrombosis: 7 documents. He has co-authored several international guidelines and consensus statements: • ESMO Guidelines on cancer-associated VTE (Annals of Oncology 2023; PMID: 36638869). • Multidisciplinary Consensus on Pulmonary Embolism (Arch Bronconeumol 2021). • Consensus on Optimal Management of Pulmonary Embolism (Eur Heart J 2022; PMID: 34875048). • Panelist in iTAC Guidelines on cancer-associated VTE (Lancet Oncology 2019 and 2022; PMID: 31492632 and 35772465). His H-index is 33 (Web of Science). Supervised PhD Theses and Master’s Dissertations (last 5 years) 1. Dr. Samira Marín Romero – PhD, Universidad de Sevilla (2020). Long-term treatment controversies in patients with unprovoked venous thromboembolism and cancer-associated thrombosis. Grade: Summa Cum Laude. Thesis by com-pendium of articles. 2. Dr. Sergio López Ruz – PhD, Universidad de Sevilla (2023). Therapeutic ma-nagement controversies in venous thromboembolism in complex patients. Grade: Outstanding. Thesis by compendium of articles. 3. Dr. María Barca Hernando – PhD, Universidad de Sevilla (2024). Venous thromboembolism in cancer patients: therapeutic management and complica-tions. Grade: Summa Cum Laude. Thesis by compendium of articles. 4. Dr. Aurora Solier López – PhD, Universidad de Sevilla (2024). Duration of an-ticoagulant treatment in cancer-associated venous thromboembolism. Grade: Summa Cum Laude. 5. Dr. Lucía Marín Barrera – PhD, Universidad de Sevilla (2025). Health-related quality of life in cancer patients with acute symptomatic venous thromboembo-lism. A case-control study. Grade: Summa Cum Laude. PhD theses pending defense in 2025: Víctor García García, Carmen Rosa Linares. Master’s Teaching Activities • Master in Clinical Research Methodology in Pulmonary Embolism (3 edi-tions). • Master in VTE, University of Navarra (2021–22 and 2023–24). • Vascular Master’s, CEU San Pablo University (2023–24). Human Resources Supervision • Rio Hortega Fellowship (ISCIII): CM20/00162 – Beneficiary: Samira Marín Romero. PI: Luis Jara Palomares. Center: Hospital Universitario Virgen del Rocío / IBIS (2021–2023). • Rio Hortega Fellowship (ISCIII): CM22/00234 – Beneficiary: María Barca Hernando. PI: Luis Jara Palomares. Center: Hospital Universitario Virgen del Ro-cío / IBIS (2023–2024). • Research Intensification Grant – ISCIII (2023–2024). • Junior Specialist Postdoctoral Contract, Andalusian Health Ministry: RHE-0028-2024. Beneficiary: María Barca Hernando. Teaching of Health Sciences Trainees (FSE) • Clinical tutor (PI, co-PI) of 4th- and 6th-year medical students, Universidad de Sevilla. • Clinical tutor (PI, co-PI) of internal medicine, vascular medicine, and pulmonolo-gy residents rotating in the Venous Thromboembolism Unit at Hospital Universi-tario Virgen del Rocío. Head of the Unit From October 2025